Blood Podcast

American Society of Hematology

Acute Myeloid Leukemia

Multiple Myeloma

Sickle Cell Disease

Diffuse Large B-Cell Lymphoma

Chronic Lymphocytic Leukemia

Chronic Myeloid Leukemia

Venetoclax

CAR T-Cell Therapy

Clinical Trials

Transfusion Medicine

Follicular Lymphoma

Mantle Cell Lymphoma

Graft-Versus-Host Disease

Acute Lymphoblastic Leukemia

Myelodysplastic Syndromes

Tyrosine Kinase Inhibitors

Hematology

Venous Thromboembolism

Thrombosis

Minimal Residual Disease

Stay up to date on the latest research and reviews for both clinical and basic hematology with Blood podcast, published weekly in conjunction with each issue of Blood. Additionally, Blood review series podcasts feature in depth discussion with authors of recently published review articles. Subscribe and never miss a new episode.

115 ratings

Publishes	Weekly	Episodes	390	Founded	7 years ago
Number of Listeners		Categories	Health & FitnessScienceMedicine

Listen to this Podcast

Guests Hosts Reviews Charts Talking Points

Latest Episodes

FLT3-ITD microclones in AML and Results from the RESET-PV trial

In this week's episode, Blood editor Dr. Laura Michaelis interviews Drs. Pierre-Yves Dumas and Samik Basu on their latest articles published in Blood. Dr. Dumas talks about "Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid... more

30 Jul 2026 • 13 min

Initial CHORUS data on HHT and ASH HematOmics Program

In this week's episode, Blood editor Dr. James Griffin interviews Drs. Hanny Al-Samkari and Xin Zhou on their latest articles published in Blood. This episode highlights two important advances in hematology: the first report from the CHORUS registry ... more

23 Jul 2026 • 26 min

IV Iron during Acute Infection and Revisiting iTTP Refractoriness

In this week's episode, Blood editor Dr. James Griffin interviews Drs. Haris Sohail and Lucas Kühne on their latest articles published in volume 147 issue 21 of Blood. In this CME article titled, "Retrospective, Real-World Study of IV Iron Use to Tre... more

16 Jul 2026 • 16 min • Most popular

A Pediatric ITP Risk Model and Targeting CD2 with CAR T-cell therapies

In this week's episode, Blood editor Dr. Laura Michaelis interviews Drs. Kirsty Hillier and Marco Ruella on their latest articles published in Blood. For "Predicting Development of Pediatric Chronic Immune Thrombocytopenia at Disease Onset Using a St... more

9 Jul 2026 • 18 min • Popular

Key Facts

Accepts Guests

Contact Information

Podcast Host

Number of Listeners

Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc DocsSam and Karine

The HematologistThe Hematologist

HemeTalks: Conversations in Hematology EducationAmerican Society of Hematology

Blood Cancer TalksRajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff

NEJM This WeekNEJM Group

Recent Guests

Hanny Al-Samkari

MD discussing the CHORUS registry and HHT

Mass General Hospital

Episode: Initial CHORUS data on HHT and ASH HematOmics Program

Xin Zhou

PhD discussing the ASH Hematomics Program (ASH HOP)

St. Jude Children's Research Hospital

Episode: Initial CHORUS data on HHT and ASH HematOmics Program

Haris Sohail

Author presenting the IV iron real-world study

Hemato-Oncology Department, Charleston, West Virginia

Episode: IV Iron during Acute Infection and Revisiting iTTP Refractoriness

Lucas Kühne

First author discussing ITTP refractoriness

Germany (German-Austrian registry context)

Episode: IV Iron during Acute Infection and Revisiting iTTP Refractoriness

Kirsty Hillier

First author on the pediatric ITP risk model

NYU Grossman School of Medicine

Episode: A Pediatric ITP Risk Model and Targeting CD2 with CAR T-cell therapies

Marco Ruella

Senior author discussing CD2 CAR T-cell therapy

University of Pennsylvania

Episode: A Pediatric ITP Risk Model and Targeting CD2 with CAR T-cell therapies

Heinz Zoller

Co-author discussing ferric carboxymaltose study

Christian Doppler Laboratory for Iron and Phosphate Biology, Medical University of Innsbruck, Innsbruck, Austria

Episode: IV Iron Risks and Low-Dose AML Gains

Raul Ribeiro

Co-author discussing pediatric AML low-dose induction trial

Division of Leukemia and Lymphoma, Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA

Episode: IV Iron Risks and Low-Dose AML Gains

Olivier Hermine

Senior author, VEXAS anemia study

Université Paris-Cité

Episode: Orca-T for GVHD–free survival and Understanding VEXAS anemia

Hosts

Laurie Sehn

Host of Conversations with Blood Authors; Blood Journal / American Society of Hematology

Laura Michaelis

Host of Conversations with Blood Authors; American Society of Hematology (ASH)

James Griffin

Host of Blood Podcast; American Society of Hematology / Dana-Farber Cancer Institute (as mentioned)

Reviews

4.2 out of 5 stars from 115 ratings

Great podcast that I learned to weekly
Podcast Addict
5
ZGDave
8 days ago
Zzzz
Listened to a 17-minute episode on Mantle Cell Lymphoma. The first 3 minutes were spent ego-stroking. The podcast content was relevant (though very surface level), but the presentation was so sleepy and boring.
Apple Podcasts
3
Pectown
United States4 months ago
Needs more conversations with better sounding audio
Either sounds like AI summaries or conversations with terrible audio. All the guests are great. Hosts are terrible sounding.
Apple Podcasts
2
adammgaines
United States9 months ago
Needs more conversations with better sounding audio
Either sounds like AI summaries or conversations with terrible audio
Apple Podcasts
1
adammgaines
United Statesa year ago
That’s not how you do a podcast.
Have to agree with other reviewers. The computer generated reader is ghastly.
Apple Podcasts
1
Detritus2099
Australia3 years ago

Embed These Reviews on a Website

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Guests and topics are praised for depth and relevance to hematology.

Audio quality and pacing are common complaints; some listeners feel the narration is robotic or read-like.

High-value scientific content is noted, with calls for more conversational formats to boost engagement.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts	#150	France/Science
Apple Podcasts	#98	Sweden/Science
Apple Podcasts	#137	Japan/Science
Apple Podcasts	#166	Finland/Science
Apple Podcasts	#226	India/Science
Apple Podcasts	#230	Philippines/Science

Talking Points

Recent interactions between the hosts and their guests.

IV Iron during Acute Infection and Revisiting iTTP Refractoriness

Q: How many of those 204 ITTP episodes treated with caplacizumab ended up having a secondary disorder contributing to failure to respond?

About 30 of the 204 episodes had secondary factors; however, only a small number showed prolonged thrombocytopenia or refractoriness, and those cases usually had identifiable secondary causes rather than true ITTP refractoriness.

IV Iron during Acute Infection and Revisiting iTTP Refractoriness

Q: Thank you. Dr. Sohail, how large was this study? How many patients were involved?

The study included almost 50,000 patients across infections like UTI, pneumonia, MRSA bacteremia, and cellulitis, with substantial subgroup counts; overall, it leveraged a large national database to compare those who received IV iron versus matched controls.

Initial CHORUS data on HHT and ASH HematOmics Program

Q: When can we expect to know whether the new treatments work, and what are the bases of these therapies?

There are several new treatments in clinical trials targeting angiogenesis pathways and coagulation; early data show potential, and ongoing trials across vascular and hemostasis targets aim to reduce bleeding and disease burden.

Initial CHORUS data on HHT and ASH HematOmics Program

Q: Does the syndrome that results from these mutations all look the same, or are there differences among the five genes?

There are differences; mutations in multiple genes cause HHT, with Endoglin and ACVRL1 being the most common, and certain mutations predicting organ-specific risks like brain or liver AVMs; overall, genetics matter for disease manifestation and testing is recommended.

Orca-T for GVHD–free survival and Understanding VEXAS anemia

Q: Could you briefly describe your study methodology and the key findings of your study?

Dr. Hermine describes a combination of clinical observation in patients with VEXAS, extensive analysis of erythroid cells from bone marrow, proteomic and ubiquitination studies, and genome editing in CD34+ cells to model early erythroblast death. The findings show that erythroid cells with the UBA1 mutation have impaired ribosome biogenesis and P53 accumulation due to down-regulated MDM2, leading to cell death and explaining the macrocytic anemia and inflammatory milieu.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Blood Podcast

What is Blood Podcast about and what kind of topics does it cover?

The show centers on hematology, translational medicine, and related clinical trials, with in-depth discussions of recent Blood Journal findings, novel therapies, and the real-world impact of emerging treatments. Episodes frequently feature physician-scientists and clinical researchers examining mechanisms, translational pathways, and trial results, from clonal hematopoiesis and platelet signaling to CAR-T therapies and hepcidin biology. A notable strength is the strong emphasis on mechanistic context and translational potential, often pairing clinical questions with cutting-edge basic science. Some episodes also explore health policy and access issues, such as global availability of CAR-T therapies and HTA-driven reimbursement dynamics. A p... more

Where can I find podcast stats for Blood Podcast?

Rephonic provides a wide range of podcast stats for Blood Podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Blood Podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Blood Podcast get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Blood Podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Blood Podcast?

Rephonic provides comprehensive predictive audience data for Blood Podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Blood Podcast have?

To see how many followers or subscribers Blood Podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Blood Podcast?

These podcasts share a similar audience with Blood Podcast:

1. Two Onc Docs
2. The Hematologist
3. HemeTalks: Conversations in Hematology Education
4. Blood Cancer Talks
5. NEJM This Week

How many episodes of Blood Podcast are there?

Blood Podcast launched 7 years ago and published 390 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Blood Podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Blood Podcast?

Rephonic pulls ratings and reviews for Blood Podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Blood Podcast?

Rephonic provides full transcripts for episodes of Blood Podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Blood Podcast?

Recent guests on Blood Podcast include:

1. Hanny Al-Samkari
2. Xin Zhou
3. Haris Sohail
4. Lucas Kühne
5. Kirsty Hillier
6. Marco Ruella
7. Heinz Zoller
8. Raul Ribeiro

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.

Try it free for 7 days